Skip to main content
. 2018 Feb 20;12(2):e0006285. doi: 10.1371/journal.pntd.0006285

Table 3. Comparative acute-phase diagnostic likelihood ratios and post-test probabilities for accurately detecting human leptospirosis by DPP assay using finger stick blood (FSB), venous whole blood (VWB), and serum, by serum IgM-ELISA, and by clinical impression for 96 patients–Salvador, Brazil 2012.

Test/Specimen type by patient group Positive LR
(95% CI)
Positive Post-TP,
by level of Pre-TP
Negative LR
(95% CI)
Negative Post-TP,
by level of Pre-TP
L M H L M H
Classic leptospirosis
    DPP/FSB 4.73 (2.61–8.59) 54.2 82.5 95.0 0.09 (0.02–0.35) 2.2 8.3 26.5
    DPP/VWB 3.77 (2.30–6.18) 48.5 79.0 93.8 0.05 (0.05–0.34) 1.2 4.8 16.7
    DPP/Serum 6.67 (3.11–14.32) 62.5 87.0 96.4 0.17 (0.07–0.42) 4.1 14.5 40.5
    IgM-ELISA/Serum 37.15 *(5.30–260.52) 90.3 97.4 99.3 0.20 (0.09–0.43) 4.7 16.5 44.1
    Clinical impression 2.26 (1.61–3.18) 36.1 69.3 90.0 0.06 (0.01–0.45) 2.5 5.7 19.4
Meningitis
    DPP/FSB 2.27 (0.51–10.01) 36.2 69.4 90.1 0.73 (0.34–1.54) 15.4 42.2 74.5
    DPP/VWB 6.80 (1.72–26.86) 63.0 87.2 96.5 0.23 (0.04–1.32) 5.4 18.7 47.9
    DPP/Serum 9.60 (1.26–72.96) 70.6 90.6 97.5 0.43 (0.15–1.26) 9.7 30.1 63.2
    IgM-ELISA/Serum 13.60 (1.93–95.71) 77.3 93.2 98.2 0.21 (0.04–1.23) 5.0 17.4 45.7

DPP = Dual Path Platform; CI = confidence interval; LR = likelihood ratio; Post-TP = post-test probability; VWB = venous whole blood; ELISA = enzyme-linked immunosorbent assay; Pre-TP = pre-test probability; the clinical Pre-TP of leptospirosis was designated as low, moderate, or high; L = low clinical Pre-TP of leptospirosis (20%); M = moderate clinical Pre-TP (50%); H = high clinical Pre-TP (80%); NA = not applicable; Undefined = contains operation divisible by zero. Values not calculated for clinical impression among meningitis patients.

*Positive LR underestimates the true value, as 45 was used as number of true negatives and one was used as false negative in order to avoid division by zero.